XML 23 R11.htm IDEA: XBRL DOCUMENT v3.19.2
Investments
12 Months Ended
Dec. 31, 2018
Investments [Abstract]  
Investments
Investments

On November 28, 2018, the Company completed the Aetna Acquisition. Prior to the Aetna Acquisition Date, the Company’s short term investments balance was comprised of certificates of deposit with initial maturities of greater than three months when purchased that mature in less than one year from the balance sheet date. These investments totaled $111 million as of December 31, 2017 and were classified as available for sale. In addition, the Company had $112 million of additional long-term investments as of December 31, 2017 which primarily consisted of cost method and equity method investments. Since the total amount of investments prior to the Aetna Acquisition was not material to the consolidated financial statements, the Company will include additional disclosures for investments on a prospective basis starting from the Aetna Acquisition Date.

Total investments at December 31, 2018 were as follows:
In millions
Current
 
Long-term
 
Total
Debt securities available for sale
$
2,359

 
$
12,896

 
$
15,255

Mortgage loans
145

 
1,216

 
1,361

Other investments
18

 
1,620

 
1,638

Total investments
$
2,522

 
$
15,732

 
$
18,254

 
 
 
 
 
 


At December 31, 2018, the Company held investments of $531 million related to the 2012 conversion of an existing group annuity contract from a participating to a non-participating contract. The conversion occurred prior to the Aetna Acquisition. These investments are included in the total investments of large case pensions supporting non-experience-rated products. Although these investments are not accounted for as Separate Accounts assets, they are legally segregated and are not subject to claims that arise out of the Company’s business and only support future policy benefits obligations under that group annuity contract.
Debt Securities

Debt securities available for sale at December 31, 2018 were as follows:
In millions
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair
Value
December 31, 2018
 
 
 
 
 
 
 
Debt securities:
 
 
 
 
 
 
 
U.S. government securities
$
1,662

 
$
26

 
$

 
$
1,688

States, municipalities and political subdivisions
2,370

 
30

 
(1
)
 
2,399

U.S. corporate securities
6,444

 
61

 
(16
)
 
6,489

Foreign securities
2,355

 
31

 
(3
)
 
2,383

Residential mortgage-backed securities
567

 
10

 

 
577

Commercial mortgage-backed securities
594

 
11

 

 
605

Other asset-backed securities
1,097

 
3

 
(15
)
 
1,085

Redeemable preferred securities
30

 

 
(1
)
 
29

Total debt securities (1)
$
15,119

 
$
172

 
$
(36
)
 
$
15,255

 
 
 
 
 
 
 
 
_____________________________________________ 
(1)
Investment risks associated with the Company’s experience-rated products generally do not impact the Company’s consolidated results of operations. At December 31, 2018, debt securities with a fair value of $916 million, gross unrealized capital gains of $12 million and gross unrealized capital losses of $2 million were included in total debt securities, but support experience-rated products.

The fair value of debt securities at December 31, 2018 is shown below by contractual maturity.  Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.
In millions
Amortized Cost
 
Fair Value
Due to mature:
 
 
 
Less than one year
$
901

 
$
902

One year through five years
5,489

 
5,521

After five years through ten years
2,973

 
2,999

Greater than ten years
3,498

 
3,566

Residential mortgage-backed securities
567

 
577

Commercial mortgage-backed securities
594

 
605

Other asset-backed securities
1,097

 
1,085

Total
$
15,119

 
$
15,255

 
 
 
 


Mortgage-Backed and Other Asset-Backed Securities
All of the Company’s residential mortgage-backed securities at December 31, 2018 were issued by the Government National Mortgage Association, the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation and carry agency guarantees and explicit or implicit guarantees by the United States Government. At December 31, 2018, the Company’s residential mortgage-backed securities had an average credit quality rating of AAA and a weighted average duration of 4.8 years.

The Company’s commercial mortgage-backed securities have underlying loans that are dispersed throughout the United States. Significant market observable inputs used to value these securities include loss severity and probability of default.  At December 31, 2018, these securities had an average credit quality rating of AAA and a weighted average duration of 6.3 years.

The Company’s other asset-backed securities have a variety of underlying collateral (e.g., automobile loans, credit card receivables, home equity loans and commercial loans). Significant market observable inputs used to value these securities include the unemployment rate, loss severity and probability of default. At December 31, 2018, these securities had an average credit quality rating of AA and a weighted average duration of 1.3 years.
Summarized below are the debt securities the Company held at December 31, 2018 that were in an unrealized capital loss position:
In millions, except number of securities
Number of Securities
 
Fair
Value
 
Unrealized
Losses
Debt securities:
 
 
 
 
 
U.S. government securities
8

 
$
26

 
$

States, municipalities and political subdivisions
54

 
86

 
1

U.S. corporate securities
1,399

 
1,431

 
16

Foreign securities
243

 
314

 
3

Residential mortgage-backed securities
45

 
1

 

Other asset-backed securities
516

 
528

 
15

Redeemable preferred securities
14

 
23

 
1

Total debt securities
2,279

 
$
2,409

 
$
36

 
 
 
 
 
 


Since Aetna’s investment portfolio was measured at fair value as of the Aetna Acquisition Date, each of the securities in the table above were in an unrealized loss position for less than 12 months. The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company’s businesses. In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company’s internal credit analysts and external rating agencies and the prospects of realizing the carrying value of the security based on the investment’s current prospects for recovery. As of December 31, 2018, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to anticipated recovery of their amortized cost basis.

The maturity dates for debt securities in an unrealized capital loss position at December 31, 2018 were as follows:
 
Supporting experience-rated products
 
Supporting remaining
products
 
Total
In millions
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Due to mature:
 
 
 
 
 
 
 
 
 
 
 
Less than one year
$
21

 
$

 
$
308

 
$

 
$
329

 
$

One year through five years
36

 
2

 
557

 
5

 
593

 
7

After five years through ten years
47

 

 
492

 
9

 
539

 
9

Greater than ten years
49

 

 
370

 
5

 
419

 
5

Residential mortgage-backed securities

 

 
1

 

 
1

 

Other asset-backed securities
4

 

 
524

 
15

 
528

 
15

Total
$
157

 
$
2

 
$
2,252

 
$
34

 
$
2,409

 
$
36

 
 
 
 
 
 
 
 
 
 
 
 


Mortgage Loans

The Company’s mortgage loans are collateralized by commercial real estate. From the Aetna Acquisition Date through December 31, 2018, the Company had the following activity in its mortgage loan portfolio:
In millions
 
New mortgage loans
$
4

Mortgage loans fully-repaid
27

Mortgage loans foreclosed


The Company assesses mortgage loans on a regular basis for credit impairments, and annually assign a credit quality indicator to each loan.  The Company’s credit quality indicator is internally developed and categorizes its portfolio on a scale from 1 to 7.  These indicators are based upon several factors, including current loan-to-value ratios, property condition, market trends, creditworthiness of the borrower and deal structure. The vast majority of the Company’s mortgage loans fall into categories 2 to 4.

Category 1 - Represents loans of superior quality
Categories 2 to 4 - Represents loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.
Categories 5 and 6 - Represents loans where credit risk is not substantial, but these loans warrant management’s close attention.
Category 7 - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.

Based upon the most recent assessments at December 31, 2018, the Company’s mortgage loans were given the following credit quality indicators:
In millions, except credit ratings indicator
 
1
$
42

2 to 4
1,301

5 and 6
18

7

Total
$
1,361

 
 

At December 31, 2018 scheduled mortgage loan principal repayments were as follows:
In millions
 
2019
$
145

2020
109

2021
269

2022
228

2023
83

Thereafter
527

Total
$
1,361

 
 


Net Investment Income

Sources of net investment income for the year ended December 31, 2018 were as follows:
In millions
 
Debt securities
$
61

Mortgage loans
6

Other investments
593

Gross investment income
660

Investment expenses
(3
)
Net investment income (excluding net realized capital gains or losses)
657

Net realized capital gains
3

Net investment income (1)
$
660

 
 
_____________________________________________ 
(1)
Net investment income in 2018 includes $4 million related to investments supporting experience-rated products.

The Company’s net investment income was $21 million and $20 million in 2017 and 2016, respectively, relating to interest income on cash equivalents and debt securities. The Company did not have any material realized capital gains or losses during 2017 or 2016.

The portion of unrealized capital gains and losses recognized during the year ended December 31, 2018 related to investments in equity securities held as of December 31, 2018 was not material.

Excluding amounts related to experience-rated products, proceeds from the sale of available for sale debt securities and the related gross realized capital gains and losses from the Aetna Acquisition Date through December 31, 2018 were as follows:(1) 
In millions
 
Proceeds from sales
$
389

Gross realized capital gains
2

Gross realized capital losses
(2
)
 
 
_____________________________________________ 
(1)
The proceeds from sales and gross realized capital gains and losses exclude the impact of the sales of short-term debt securities which primarily relate to the Company’s investments in mutual funds. These investments were excluded from the disclosed amounts because they represent an immaterial amount of aggregate gross realized capital gains or losses and have a high volume of sales activity.